Clinical & Molecular Biomedicine (CMB) is committed to the principles of open access publishing and the broad dissemination of scientific knowledge. All articles published in the journal are made available through a fully open-access model, ensuring immediate and unrestricted access to readers worldwide.

All published articles are freely available online without subscription barriers. Readers may access, read, download, and share published content without institutional or financial restrictions.

This policy supports the journal’s aim to promote equitable access to scientific knowledge and to ensure that biomedical research can reach researchers, clinicians, educators, policymakers, and the wider scientific community.

Clinical & Molecular Biomedicine operates as a Gold Open Access journal. Published articles are made openly available immediately upon publication on the journal platform.

Currently, no article processing charges (APCs) are required for publication in Clinical & Molecular Biomedicine.

Authors retain full copyright ownership of their work.

Articles are published under the Creative Commons Attribution (CC BY) license, which permits redistribution, reuse, adaptation, and commercial use, provided that appropriate credit is given to the original authors and source.

Under this license, users may:

• Copy and redistribute the material in any medium or format

• Remix, transform, and build upon the material

• Use the material for any purpose, including commercial purposes

Users must provide appropriate credit to the original authors and the journal, provide a link to the license, and indicate if changes were made.

By publishing with Clinical & Molecular Biomedicine, authors grant the journal the right to publish, distribute, and promote the article as the Version of Record under the selected open access license.

Authors are encouraged to share the final published article through institutional repositories, personal websites, academic networks, and professional communication channels, provided that the original source is properly acknowledged.

Open access publication provides several benefits, including:

• Increased accessibility of published research

• Greater visibility and potential impact

• Wider dissemination among researchers and healthcare professionals

• Support for compliance with institutional and funder open access requirements

• Promotion of equitable access to scientific knowledge regardless of institutional or financial constraints

Clinical & Molecular Biomedicine supports open, transparent, and reproducible research practices. The journal encourages authors to share research data, methods, protocols, and supporting materials where ethically and legally appropriate.